Overview
Updated 14 Jul 2026
Parameswaran Hari, MD, is Chief Development Officer at Obsidian Therapeutics. The public record shows 917 publications with 27,053 citations (h-index 79), centered on Multiple Myeloma Research and Treatments, Hematopoietic Stem Cell Transplantation, CAR-T cell therapy research. It also documents an investigator role on 6 registered clinical trials, industry payments reported by 16 companies, 2 NIH-funded awards (2017–2020).
- Most recent indexed publication: 2025 · Journal of clinical oncology
- Top research focus: Multiple Myeloma Research and Treatments
- 6 registered trials on ClinicalTrials.gov
- Open Payments reporting from 16 companies
Generated from the cited public record · current as of 14 Jul 2026. Every fact links its source below.
Indications focusfrom trials led + research topics
Research focusOpenAlex concept fingerprint
Drugs & moleculesacross trials, industry payments and publications
Works withtrial sponsors and companies reporting payments
Scholarshipindexed output and impact (OpenAlex)
View publications ↓Distinct works indexed by OpenAlex, matched via ORCID; 20 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 354.
Clinical & industrytrials, payments and federal funding
Clinical trials
Updated 14 Jul 2026
Listed as an investigator on 6 registered studies on ClinicalTrials.gov. The most recent:
- S1803, Lenalidomide +/- Daratumumab/rHuPh20 as Post-ASCT Maintenance for MM w/MRD to Direct Therapy Duration
Sponsor: SWOG Cancer Research Network
InvestigatorPhase 3Active, not recruitingNCT04071457 - Tinostamustine Conditioning and Autologous Stem Cell
Sponsor: Mundipharma-EDO GmbH
InvestigatorPhase 1/PHASE2TerminatedNCT03687125 - Assessment of Allogeneic Hematopoietic Cell Transplantation in Medicare Beneficiaries With Multiple Myeloma
Sponsor: Center for International Blood and Marrow Transplant Research
InvestigatorRecruitingNCT03127761
Industry payments
Updated 14 Jul 2026
16 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- PFIZER INC.Program year202518 payments$282,000openpaymentsdata.cms.gov ↗
- GlaxoSmithKline, LLC.Program year20254 payments$47,300openpaymentsdata.cms.gov ↗
- PFIZER INC.Program year202417 payments$414,438openpaymentsdata.cms.gov ↗
NIH funding
Updated 14 Jul 2026
2 NIH research awards on record, funded 2017–2020 per NIH RePORTER. The latest:
- A Phase I Clinical Trial Testing Feasibility of Hematopoietic Stem Cell Gene Therapy Using Platelet Factor VIII to Safely Improve Hemostasis for Severe Hemophilia A with Inhibitory Antibodies
Medical College of Wisconsin
FY2020$1,596,167R01HL142791 - Core Clinical Centers for the Blood and Marrow Transplant Clinical Trials Network
Medical College of Wisconsin
FY2020$184,800UG1HL138641 - A Phase I Clinical Trial Testing Feasibility of Hematopoietic Stem Cell Gene Therapy Using Platelet Factor VIII to Safely Improve Hemostasis for Severe Hemophilia A with Inhibitory Antibodies
Medical College of Wisconsin
FY2019$1,774,215R01HL142791
Congress activity
Updated 14 Jul 2026
151 congress contributions (2006–2025) across AACR, ASCO, ASH, ESMO per OpenAlex. The most recent:
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 14 Jul 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
Most-cited worksby citation count (OpenAlex)
Contact
An office address from a public listing. This research profile has no federal registry record to draw from.
Office address
9200 W Wisconsin Ave, Milwaukee, WI 53226
Network
Updated 14 Jul 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Background & recognition
Updated 14 Jul 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Educationdegrees and training on record
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →ascopost.com ↗
- MBBS
University of Kerala
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →obsidiantx.com ↗ - MS
Medical College of Wisconsin
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →obsidiantx.com ↗ - MRCP (Member of the Royal College of Physicians)
UK internal medicine/hematology training
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →ascopost.com ↗ - Board Certified
Internal Medicine (American Board of Medical Specialties)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →healthgrades.com ↗ - Board Certified
Medical Oncology (American Board of Medical Specialties)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →healthgrades.com ↗
Editorial & leadership rolesjournal and society appointments
- Chief Development Officer
Obsidian Therapeutics
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →obsidiantx.com ↗ - Secretary
American Society for Transplantation and Cellular Therapy (ASTCT)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ascopost.com ↗ - Formerly Chief of the Division of Hematology and Oncology
Medical College of Wisconsin
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →obsidiantx.com ↗
Secondary affiliationsappointments beyond the home institution
- Formerly Director
Adult Blood and Marrow Transplant Program, Medical College of Wisconsin
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →mcw.edu ↗ - Data coordination role
Center for International Blood & Marrow Transplant Research (CIBMTR) / BMT CTN
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →ascopost.com ↗
Media & interviewspress, podcasts and appearances
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →vjhemonc.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →onclive.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Online presence
Updated 14 Jul 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accountspublic accounts run by this person
- Doximity
doximity.com/pub/parameswaran-hari-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - ResearchGate
researchgate.net/profile/Parameswaran-Hari
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
Mentions by otherswhere others cite or feature them
- Instagram
instagram.com/p/DUbYEgKkpTI
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →instagram.com ↗ - Other
theorg.com/org/obsidian-therapeutics/org-chart/parameswaran-hari
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →theorg.com ↗ - Other
curetalks.com/improvements-in-myeloma-survival-with-dr-parameswaran-hari
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →curetalks.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Michael Widlansky, MD
Medical College of Wisconsin
- 172
- publications
- 34
- h-index
- 9
- trials
Binod Dhakal, MD
Medical College of Wisconsin
- 483
- publications
- 35
- h-index
- 7
- trials
Ehab Atallah, MD
Medical College of Wisconsin
- 361
- publications
- 35
- h-index
- 16
- trials